Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price traded up 2.1% during mid-day trading on Thursday . The company traded as high as $1.95 and last traded at $1.94. 371,750 shares changed hands during trading, an increase of 454% from the average session volume of 67,097 shares. The stock had previously closed at $1.90.
Cardiol Therapeutics Price Performance
The firm has a 50-day moving average price of $2.03 and a 200 day moving average price of $2.08.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
See Also
- Five stocks we like better than Cardiol Therapeutics
- There Are Different Types of Stock To Invest In
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Best Aerospace Stocks Investing
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.